Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19106, United States
NCT Number: NCT01975792
The thymus gland is a specialized organ in the chest that plays a central role in the adaptive immune system throughout development until puberty. In response to stress, the fetal thymus gland may shrink, or involute. The investigators propose a prospective cohort study that will enroll pregnant women admitted to labor and delivery for the management of preterm labor and/or preterm premature rupture of membranes from 28-36 weeks gestation. Based on sonographic thymus measurements, the investigators will develop a clinical prediction tool to identify babies who are at increased risk for adverse neonatal outcomes. A reliable non-invasive predictor of adverse neonatal outcome using thymic ultrasound measurements has the potential to affect clinical management, improve outcomes for premature babies, and direct further research efforts.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Philadelphia, Pennsylvania, 19106, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Date of delivery up to 1 year
Neonatal respiratory compromise defined as respiratory distress requiring any CPAP (continuous positive airway pressure) and or ventilator therapy.
University of Pennsylvania
Other
Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcome in Women at High Risk for Preterm Delivery
Acronym: TIPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04705935
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Aarhus, Denmark
View Trial DetailsNCT06074601
Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Diego, California, United States
View Trial DetailsNCT04047849
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Baton Rouge, Louisiana, United States
View Trial DetailsNCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial Details